@article{article, title  = {{Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{https://doi.org/10.1007/s13555-026-01745-7 }},

 year = {{2026}},

 month = {{4}},

 author = {{Paller AS and Cork MJ and Hong HC-H and Soong W and Schneider SKR and Lo H and Vinther F and Thøgersen P and Wollenberg A}},

 doi = {{10.1007/s13555-026-01745-7}},

 journal = {{Dermatology and Therapy}},

 note = {{Accessed on 2026/05/14}}}